moxifloxacin has been researched along with lupeol in 1 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (lupeol) | Trials (lupeol) | Recent Studies (post-2010) (lupeol) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 466 | 0 | 266 |
Protein | Taxonomy | moxifloxacin (IC50) | lupeol (IC50) |
---|---|---|---|
Cocaine esterase | Homo sapiens (human) | 1.9 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.12 | |
Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguinaldo, MA; Chen, X; Cordell, GA; Decker, M; Franzblau, SG; Galvez, EV; Heilmann, J; Macabeo, AP; Vidar, WS; Wan, B | 1 |
1 other study(ies) available for moxifloxacin and lupeol
Article | Year |
---|---|
Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa.
Topics: Acetylcholinesterase; Alkaloids; Animals; Antitubercular Agents; Butyrylcholinesterase; Cholinesterase Inhibitors; Electrophorus; Horses; Indole Alkaloids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Pentacyclic Triterpenes; Plant Extracts; Plant Leaves; Spiro Compounds; Structure-Activity Relationship; Voacanga; Xanthenes | 2011 |